Olinciguat clinical trials
Also written IW-1701.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How each study uses olinciguat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses olinciguat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)CompletedPhase 2Cyclerion TherapeuticsNCT03285178Written as IW-1701
- Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II AchalasiaTerminatedPhase 2Cyclerion TherapeuticsNCT02931565Written as Olinciguat
- A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy VolunteersCompletedPhase 1Cyclerion TherapeuticsNCT03892499Written as Olinciguat
- A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male VolunteersCompletedPhase 1Cyclerion TherapeuticsNCT03795519Written as [14C]-olinciguat
- Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy VolunteersCompletedPhase 1Cyclerion TherapeuticsNCT02572349Written as IW-1701
- A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy SubjectsCompletedPhase 1Cyclerion TherapeuticsNCT02792998Written as IW-1701
Codes
What other systems call olinciguat · ClinicalTrials.gg INT017570
- UNII (FDA) PD5F4ZXD21OLINCIGUATConfirmed FDA, Wikidata
- Wikidata Q76803668olinciguatConfirmed FDA, Wikidata
- NCI Thesaurus C153148OlinciguatOne source FDA
- DrugBank DB15238One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | PD5F4ZXD21 | OLINCIGUAT | Confirmed FDA, Wikidata |
| Wikidata | Q76803668 | olinciguat | Confirmed FDA, Wikidata |
| NCI Thesaurus | C153148 | Olinciguat | One source FDA |
| DrugBank | DB15238 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.